Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters

Oral Oncology

Volumn 36, Issue 4, 2000, Pages 373-381

  Sonis, S T ^a,b   Peterson, R L ^c   Edwards, L J ^a   Lucey, C A ^a   Wang, L ^c   Mason, L ^c   Login, G ^a,d   Ymamkawa, M ^d   Moses, G ^a,b   Bouchard, P ^c   Hayes, L L ^c   Bedrosian, C ^c   Dorner, A J ^c  

^a Division of Sleep Medicine   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c PFIZER INC   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

IL 11; Mechanism; Mucositis; Radiation

Indexed keywords

INTERLEUKIN 11;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTRON MICROSCOPY; HAMSTER; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; MAST CELL; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY;

ANIMALS; APOPTOSIS; CRICETINAE; DISEASE PROGRESSION; HEAD AND NECK NEOPLASMS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; INTERLEUKIN-11; KERATINS; MALE; MAST CELLS; MESOCRICETUS; MOUTH MUCOSA; ORAL ULCER; RADIATION INJURIES, EXPERIMENTAL; STOMATITIS;

EID: 0033918355     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(00)00012-9     Document Type: Article

References (17)

1. Sonis S.T. Oral complications. Holland J.F.et al. Cancer Medicine, 4th ed. 1997;3255-3264 William and Wilkins, Philadelphia.
2. Sonis S.T. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol. 34:1998;39-43.
3. Sonis S., Edwards L., Lucey C. The biological basis for the attenuation of mucositis: the example of Interleukin-11. Leukemia. 13:1999;831-834.
4. Hall P.D., Benko H., Hogan K.R., Stuart R.K. The influence of serum tumor necrosis factor-α and interleukin-6 concentrations on non-hematologic toxicity and hematologic recovery in patients with acute myelogenous leukaemia. Exp Hematol. 23:1995;1256-1260.
5. Jaenke R.S., Robbins M.E., Bywaters T., Whitehouse E., Rezvani M., Hopewell J.W. Capillary endothelium. Target site of renal radiation injury. Lab. Invest. 68:1993;346-405.
6. Neben S., Turner K. The biology of interleukin-11. Stem Cells. 11:1993;156-162.
7. Trepicchio W.L., Bozza M., Pedneault G., Dorner A.J. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol. 157:1996;3627-3634.
8. Orazi A., Du A., Yang Z., Kashai M., Williams D.A. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest. 75:1996;33-42.
9. Sonis S.T., VanVugt A.G., McDonald J., Dotoli E., Schwertschlag U., Szklut P., Keith J. Mitigating effects of interleukin-11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters. Cytokine. 9:1997;605-612.
10. Du X.X., Doerschuk C.M., Orazi A., Williams D.A. A bone marrow-stromal derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood. 83:1994;33-37.
11. Dvorak A.M. New aspects of mast cell biology. Int Arch Allergy Immunol. 114:1997;1-9.
12. Sonis S., Muska A., O'Brien J., VanVugt A., Langer-Safer P., Keith J. Eur J Cancer Part B Oral Oncol. 31B:1995;261-266.
13. Sonis A.L., Sonis S.T. Oral complications of cancer therapy in pediatric patients. J Pedodontics. 3:1979;12-16.
14. Sonis S.T., Costa J.W. Jr., Evitts S.M., Lindquist L.E., Nicolson M. Effect of epidermal growth factor on ulcerative mucositis in hamsters than receive chemotherapy. Oral Surg, Oral Med, Oral Pathol. 74:1992;749-755.
15. Sonis S.T., Linquist L., VanVugt A., Stewart A.A., Stam K., Qu G.Y.et al. Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor-β3. Cancer Res. 54:1994;1135-1138.
16. Antin J.H., Ferrara J.L. Cytokine dysregulation and acute graft-versus-host disease. Blood. 10:1992;510-520.
17. Sleijfer S., Vujaskovic Z., Limburg P.C., Schraffordt Koops H., Mulder N.H. Induction of tumor necrosis factor-alpha as a cause of bleomycin-related toxicity. Cancer. 82:1998;970-974.